title: Immune privilege, tumors, and the eye.
authors.affiliation: Schepens Eye Research Institute, Harvard Medical School, Boston, Mass., USA.
authors.forename: P W
authors.initials: PW
authors.lastname: Chen
authors.forename: B R
authors.initials: BR
authors.lastname: Ksander
mesh_terms: D000818:Animals; D017951:Antigen Presentation; D000943:Antigens, Differentiation / Q000235:genetics / Q000276:immunology; D000951:Antigens, Neoplasm / Q000235:genetics / Q000276:immunology; D017209:Apoptosis; D016228:Endothelial Growth Factors / Q000502:physiology; D005123:Eye / Q000276:immunology*; D053222:Fas Ligand Protein; D015972:Gene Expression Regulation, Neoplastic; D005805:Genes, MHC Class I; D006085:Graft Survival; D015395:Histocompatibility Antigens Class I / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology*; D007114:Immunization; D007167:Immunotherapy; D016753:Interleukin-10 / Q000502:physiology; D007694:Killer Cells, Natural / Q000276:immunology; D008222:Lymphokines / Q000502:physiology; D008562:Membrane Glycoproteins / Q000502:physiology; D051379:Mice; D009368:Neoplasm Transplantation / Q000276:immunology; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy; D011971:Receptors, Immunologic / Q000276:immunology; D054340:Receptors, KIR; D016212:Transforming Growth Factor beta / Q000502:physiology; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
chemical_list: D000943:Antigens, Differentiation; D000951:Antigens, Neoplasm; D016228:Endothelial Growth Factors; C505661:FASLG protein, human; D053222:Fas Ligand Protein; C505658:Fasl protein, mouse; D015395:Histocompatibility Antigens Class I; D008222:Lymphokines; D008562:Membrane Glycoproteins; D011971:Receptors, Immunologic; D054340:Receptors, KIR; D016212:Transforming Growth Factor beta; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D016753:Interleukin-10